India's Panacea Biotec to produce 100 million Sputnik V doses annually

 Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.

RDIF did not say when production would begin.

https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-ind/indias-panacea-biotec-to-produce-100-million-sputnik-v-doses-annually-rdif-idUSKBN2BS0Z2